Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Non-Current Liabilities (2016 - 2025)

Marimed has reported Other Non-Current Liabilities over the past 15 years, most recently at $100000.0 for Q3 2025.

  • Quarterly Other Non-Current Liabilities changed 0.0% to $100000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Sep 2025, changed 0.0% year-over-year, with the annual reading at $100000.0 for FY2024, 0.0% changed from the prior year.
  • Other Non-Current Liabilities was $100000.0 for Q3 2025 at Marimed, roughly flat from $100000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $100200.0 in Q1 2021 and troughed at $100000.0 in Q4 2021.
  • The 5-year median for Other Non-Current Liabilities is $100000.0 (2021), against an average of $100031.6.
  • The largest YoY upside for Other Non-Current Liabilities was 0.0% in 2021 against a maximum downside of 0.2% in 2021.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Non-Current Liabilities are $100000.0 (Q3 2025), $100000.0 (Q2 2025), and $100000.0 (Q1 2025).